Arcus Capital Partners’s Merck MRK Stock Holding History

Arcus Capital Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$208K	Buy	+1,615	New	+$189K	0.09%	105
2026 Q1	–	Sell	-5,414	Closed	-$570K	–	143
2025 Q4	$570K	Buy	+5,414	New	+$508K	0.2%	77
2025 Q1	–	Sell	-1,742	Closed	-$230K	–	133
2024 Q4	$230K	Buy	+1,742	New	+$180K	0.07%	99
2024 Q3	–	Sell	-1,635	Closed	-$202K	–	118
2024 Q2	$202K	Sell	1,635 -107	-6%	-$13.8K	0.08%	104
2024 Q1	$230K	Buy	+1,742	New	+$215K	0.07%	99
2023 Q1	–	Sell	-1,635	Closed	-$181K	–	258
2022 Q4	$181K	Buy	+1,635	New	+$167K	0.07%	98

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arcus Capital Partners's MRK Position: Q2 2026 in Review

Arcus Capital Partners opened a new position in Merck (MRK) in Q2 2026: 1,615 shares worth $208K. The stake represents 0.09% of the portfolio and ranks #105 among its holdings. This is a return to the name: Arcus Capital Partners previously reported a position in MRK as recently as Q4 2025.

Arcus Capital Partners first reported a position in MRK in Q4 2022 and has held it in 6 quarters since. The position peaked at $570K in Q4 2025. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Arcus Capital Partners held 1,615 shares of Merck worth $208K as of Q2 2026.
Merck was a new Arcus Capital Partners position in Q2 2026.
Merck made up 0.09% of Arcus Capital Partners's portfolio in Q2 2026, its #105 holding.
Arcus Capital Partners first reported a position in Merck in Q4 2022 and has held it in 6 quarters since.
Arcus Capital Partners's Merck position peaked at $570K in Q4 2025.
3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Arcus Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.